The newly appointed distributor brings extensive experience in biomedical research technologies and a strong network within academic institutions, hospitals, and biotech companies across the region. Through this collaboration, PHI aims to provide enhanced access to its flagship product, the HoloMonitor® system, enabling researchers in Singapore and Malaysia to conduct long-term, non-invasive live cell imaging with unprecedented clarity and precision.

"Welcoming our new distributor in Southeast Asia is a key milestone in PHI's strategy to extend our global reach", says Patrik Eschricht, CEO of Phase Holographic Imaging. "This partnership strengthens our presence in Singapore and Malaysia, aligning with our commitment to make advanced live cell imaging technologies accessible to researchers worldwide."

Gaia Bioscience Pte Ltd, headquartered in Singapore, is renowned for its commitment to advancing biomedical innovation and supporting research excellence throughout Southeast Asia. As an established distributor of scientific technologies, Gaia Bioscience collaborates closely with academic institutions, hospitals, and biotechnology companies to provide cutting-edge solutions for life science applications. By fostering partnerships and promoting the adoption of state-of-the-art products, Gaia Bioscience has played a pivotal role in accelerating scientific discovery and enabling breakthrough research across the region.

The partnership is expected to accelerate PHI's growth in Asia and support cutting-edge research in cell biology, cancer, and regenerative medicine.